Orlando, Florida, June 28, 2021 (GLOBE NEWSWIRE) – AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC Pink: AVMR) today announces the appointment of Dr. Onur Toker, a leading expert plan in electrical and computer engineering, as a senior design engineer to accelerate the development of its advanced surgical robotic system.

Dr Toker joins AVRA from Florida Poly, where he is an associate professor of electrical and computer engineering, specializing in hardware acceleration, field programmable gate networks (FPGAs), embedded systems, telerobotics and sensors.

Explaining the importance of this appointment, Barry Cohen, President and CEO of AVRA, said: The development of our robotic surgical system. With the help of Dr Toker, we should be able to accelerate the delivery of the most sophisticated combination of imaging, guidance, targeting and intelligence to help surgeons perform cosmetic and other skin care procedures. skin resurfacing.

Dr Toker added, “AVRA’s surgical intelligence software is developed to enable surgeons to deliver a level of accuracy, precision and reproducibility never seen before, improving a surgeon’s fine motor skills with the ability of a surgical robot to perform delicate tasks with precision and my work in these areas should allow us to produce an even more sophisticated model much faster than the original plans allowed ”.

As Barry Cohen summed it up: “Dr Toker will use his knowledge and skills to help us deliver a prototype of our next-generation cosmetic surgeon robot in time for the prestigious 13th 5CC World Congress in Barcelona in September 2021.”

The Company continues to work with its new independent public accounting firm to update itself in its periodic SEC reports in the near future.

For more information on AVRA Medical Robotics, visit http://www.avramedicalrobotics.com or contact the company at [email protected]

About AVRA medical robotics

AVRA Medical Robotics, Inc., (OTC Pink: AVMR) is a medical software and artificial intelligence company that builds a medical robotic system combining artificial intelligence, machine learning and proprietary software.

AVRA, known for its advancements in robotics and guidance systems, is developing a surgical robotic system that “robotizes” a wide range of surgical procedures using surgical and non-surgical devices and instruments currently performed by medical professionals. human hands.

AVRA’s initial goal in the field of medical robotics is the development of a treatment-independent precision guidance system, applicable to a variety of minimally invasive and non-invasive procedures, to take advantage of the growing demand for practical medical robotic devices, with an initial focus on cosmetic skin resurfacing procedures.

AVRA more recently leveraged the sterilization elements of its research and development work on its medical robotic system to address current and future issues highlighted by the COVID-19 pandemic.

Forward-looking statements

This press release may contain statements which are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate”, “assume”, “believe”, “estimate” , “Expect,” “will”, “intend”, “may”, “plan”, “plan”, “should”, “could”, “seek”, “designed”, “potential” , “anticipate”, “target”, “objective”, “aim” or the negative aspects of these terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or the future financial performance of AVRA and involve known and unknown risks, uncertainties and other factors that may cause our actual results, activity levels, performance or achievements to be materially different from the results, activity levels, or achievements expressed or implied by these forward-looking statements.

For more information, visit the company’s website at www.avramedical.com. For more information, contact the company at: [email protected]